JP2004509121A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509121A5
JP2004509121A5 JP2002526865A JP2002526865A JP2004509121A5 JP 2004509121 A5 JP2004509121 A5 JP 2004509121A5 JP 2002526865 A JP2002526865 A JP 2002526865A JP 2002526865 A JP2002526865 A JP 2002526865A JP 2004509121 A5 JP2004509121 A5 JP 2004509121A5
Authority
JP
Japan
Prior art keywords
phenyl
thioxo
oxo
methylene
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002526865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509121A (ja
Filing date
Publication date
Priority claimed from GBGB0021419.7A external-priority patent/GB0021419D0/en
Application filed filed Critical
Publication of JP2004509121A publication Critical patent/JP2004509121A/ja
Publication of JP2004509121A5 publication Critical patent/JP2004509121A5/ja
Pending legal-status Critical Current

Links

JP2002526865A 2000-08-31 2001-08-30 チアゾリジン誘導体および抗真菌剤としてのその使用 Pending JP2004509121A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021419.7A GB0021419D0 (en) 2000-08-31 2000-08-31 Compounds
PCT/GB2001/003860 WO2002022612A1 (en) 2000-08-31 2001-08-30 Thiazolidine derivatives and its use as antifungal agent

Publications (2)

Publication Number Publication Date
JP2004509121A JP2004509121A (ja) 2004-03-25
JP2004509121A5 true JP2004509121A5 (2) 2005-03-03

Family

ID=9898614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002526865A Pending JP2004509121A (ja) 2000-08-31 2001-08-30 チアゾリジン誘導体および抗真菌剤としてのその使用

Country Status (9)

Country Link
US (1) US6740670B2 (2)
EP (1) EP1313731B1 (2)
JP (1) JP2004509121A (2)
AT (1) ATE482954T1 (2)
AU (1) AU2001284188A1 (2)
DE (1) DE60143165D1 (2)
ES (1) ES2353685T3 (2)
GB (1) GB0021419D0 (2)
WO (1) WO2002022612A1 (2)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53252B (sr) 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
LT2653465T (lt) 2004-03-15 2016-09-12 Janssen Pharmaceutica Nv Opioidinio receptoriaus moduliatoriai
HRP20090264T1 (hr) 2004-12-09 2009-06-30 F. Hoffmann - La Roche Ag Derivati fenil-piperazin metanona
WO2006063709A1 (en) 2004-12-15 2006-06-22 F.Hoffmann-La Roche Ag Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
AU2005324024B2 (en) 2005-01-07 2011-02-17 F. Hoffmann-La Roche Ag [4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
AU2006207650B2 (en) 2005-01-18 2011-01-27 F. Hoffmann-La Roche Ag 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders
BRPI0607241A2 (pt) 2005-01-26 2009-08-25 Hoffmann La Roche derivados de fenil metanona e o uso dos mesmos como inibidores do transportador de glicina 1
DE602006010665D1 (en) 2005-02-07 2010-01-07 Hoffmann La Roche Heterocyclsche substituierte phenylmethanone als inhibitoren des glycintransporters 1
ATE536347T1 (de) 2008-05-20 2011-12-15 Merck Sharp & Dohme Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
US11292776B2 (en) 2019-12-12 2022-04-05 University Of Sharjah Small molecule inhibitors of fungal hyphae and biofilm formation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US47109A (en) * 1865-04-04 Improvement in governors
FR1604530A (2) * 1967-06-06 1971-11-29
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19835316A1 (de) * 1998-08-05 2000-02-10 Bosch Gmbh Robert Gesteuerte Gleichrichterbrücke mit Überspannungsschutz
EP1117655A1 (en) * 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders

Similar Documents

Publication Publication Date Title
JP2004509121A5 (2)
JP2004507501A5 (2)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2006509749A5 (2)
JP2003520235A5 (2)
JP2014530900A5 (2)
JP2005539088A5 (2)
JP2006517572A5 (2)
JP2020527175A5 (2)
JP2020533347A5 (2)
JP2004534035A5 (2)
JP2006500394A5 (2)
JPWO2023099623A5 (2)
JP2018514568A5 (2)
JP2010524942A5 (2)
JP2002513793A5 (2)
JP2015508097A5 (2)
JP2014523400A5 (2)
JP2003521514A5 (2)
JP2013512247A5 (2)
JP2013542267A5 (2)
JP2004517100A5 (2)
JP2007502817A5 (2)
JP2009541387A5 (2)
KR890000477A (ko) 신규 화합물들